Your browser doesn't support javascript.
loading
Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants.
Kamboj, Mini; Laracy, Justin C; Usiak, Shauna; Babady, N Esther; Yan, Judy; Seo, Susan K.
Affiliation
  • Kamboj M; Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: kambojm@mskcc.org
  • Laracy JC; Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: laracyj@mskcc.org
  • Usiak S; Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Babady NE; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yan J; Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Seo SK; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
J Infect ; 87(3): 282-285, 2023 09.
Article in En | MEDLINE | ID: mdl-37451364

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 / Antibodies, Monoclonal Limits: Humans Language: En Journal: J Infect Year: 2023 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 / Antibodies, Monoclonal Limits: Humans Language: En Journal: J Infect Year: 2023 Document type: Article Country of publication: Reino Unido